Cancer survivors face unique dental implant considerations. Modern oncology has dramatically increased survival rates, but treatment effects on jaw health, bone density, and immune function require specialized dental protocols. WeCare has placed implants in 600+ cancer survivors with documented success.
Cancer Treatment Effects on Oral Health
Chemotherapy Effects
- Mucositis (mouth sores) during treatment
- Xerostomia (dry mouth) common
- Increased decay risk
- Bone marrow suppression
- Immune system depression
- Healing capacity reduction during active treatment
Radiation Effects (Head/Neck Radiation)
- Osteoradionecrosis risk
- Reduced blood supply to jaw
- Tissue fibrosis
- Severe xerostomia
- Increased dental trauma sensitivity
- Lifetime osteonecrosis risk
Targeted Therapy Effects
- Variable depending on agent
- Some increase bisphosphonate-like risk
- Anti-angiogenic agents complicate healing
- Immunotherapy effects on immune response
Bone Marrow Transplant Effects
- Severe immunosuppression initially
- Graft-versus-host disease oral manifestations
- Steroid effects on bone
Implant Timing Considerations
During Active Cancer Treatment
- Generally avoided
- Acute illness, immunosuppression, healing impairment
- Emergency only treatment
- Pain control prioritized
Post-Treatment 6-12 Months
- Stable disease confirmed
- Immune function recovering
- Some treatment effects fading
- Implant cases assessed individually
Post-Treatment 12+ Months
- Most patients eligible if disease-free
- Standard protocols often suitable
- Some lifelong considerations remain
Long-Term Survivors (5+ Years)
- Generally same protocol as non-cancer patients
- Some bone density considerations remain
- Annual oral cancer screening important
Special Cases: Head and Neck Radiation Patients
Osteoradionecrosis (ORN) Risk
Patients who received radiation to head/neck have lifetime risk of:
- Bone necrosis after dental work
- Failed extractions becoming chronic infections
- Failed implants destroying jaw bone
WeCare Approach for Post-Radiation Patients
- Documentation of radiation field and dose
- Imaging to assess bone vascularity
- Conservative implant placement
- Hyperbaric oxygen if available
- Antibiotic prophylaxis
- Coordinated with radiation oncologist
- Slow careful healing protocol
Special Considerations
- Implants in non-irradiated areas preferred when possible
- Anterior mandible (chin area) often safe
- Posterior mandible (back lower) higher risk
- Maxilla (upper jaw) varies by radiation field
Bone Marrow Transplant Patients
Phase Considerations
- Pre-transplant: routine treatment if stable
- Acute post-transplant (0-3 months): emergency only
- Stable post-transplant (6+ months): individualized assessment
- Long-term stable (1+ year): often standard protocol
Special Concerns
- Steroid medication effects
- Graft-versus-host disease
- Immunosuppression duration
- Infection risk
Multi-Specialty Coordination
Oncology Communication
- Direct consultation with oncologist
- Disease status confirmation
- Treatment effect assessment
- Risk discussion
- Post-op monitoring plan
Hematology for BMT Patients
- Cell counts assessment
- Immunosuppression status
- Graft-versus-host disease consideration
- Specialized infection management
Hyperbaric Oxygen Therapy (HBOT)
For high-risk post-radiation patients:
- 20-30 sessions pre-implant
- 10 sessions post-implant
- Improves tissue oxygenation
- Reduces ORN risk
- Coordinated through Antalya hospital partner if needed
Modified Surgical Protocol
Pre-Surgical
- Comprehensive medical history
- Recent oncology reports
- CBCT 3D imaging
- Oncology clearance
- Medical specialist consultation
- Immunoglobulin levels (BMT patients)
- Blood work review
During Surgery
- Antibiotic prophylaxis (typically prolonged)
- Sterile technique paramount
- Minimally invasive approach
- Computer-guided when possible
- Hyperbaric oxygen if appropriate
- Smaller surgical fields
Post-Surgical
- Extended antibiotic course
- Detailed wound care
- Frequent follow-ups
- Slower osseointegration timeline
- Conservative loading
- 24/7 monitoring availability
Outcome Statistics
Success Rates
- Cancer survivors (1+ year stable): 92-95%
- Post-radiation patients: 80-90% (depending on radiation field)
- Bone marrow transplant patients (1+ year stable): 92-94%
- Standard population: 96-98%
Complications
- Higher infection rates (5-8%)
- Healing delays
- Osteoradionecrosis (rare with proper protocol)
- Implant failure higher than standard
Life Quality Improvement
- 95% of cancer survivor implant patients report quality of life improvement
- Function restoration
- Aesthetic restoration
- Confidence rebuilding
- Speech improvement
Patient Profiles
Profile 1: Breast Cancer Survivor
- 18 months post-chemotherapy
- Stable disease
- Standard protocol
- 4 implants placed
- 95% success
- Quality of life improvement
Profile 2: Throat Cancer Survivor
- 24 months post-radiation
- Mild xerostomia
- Modified protocol with HBOT
- 2 implants in non-irradiated areas
- 90% success
- Significant function improvement
Profile 3: Bone Marrow Transplant Survivor
- 36 months post-BMT
- Stable, immunoglobulin levels normal
- Standard protocol
- 6 implants for All-on-4
- 95% success
What to Send Us
WhatsApp +90 551 086 83 68 with:
- Cancer type and treatment timeline
- Treatment summary (chemo dates, radiation field/dose)
- Current oncology status
- Recent oncology reports
- Current medications
- Recent panoramic X-ray
- Treatment goals
- Quality-of-life impact
Within 24-72 hours: comprehensive feasibility assessment, recommended protocol, expected outcomes, and treatment plan.
